PCR Machines

Bruker Corporation is a global leader in high-performance scientific instruments and analytical solutions for life sciences research and diagnostics. The company manufactures a broad portfolio of analytical instruments including nuclear magnetic resonance (NMR) spectrometers, X-ray fluorescence (XRF) spectrometers, Fourier-transform infrared (FT-IR) and Raman spectrometers, electron paramagnetic resonance (EPR) systems, and advanced microscopy platforms. Bruker's diagnostic division offers the MALDI Biotyper® and IR Biotyper® systems for microbial identification, as well as the MyGenius PRO® molecular diagnostics system for sample-to-answer PCR-based infectious disease testing. The company also provides spatial biology platforms for multi-omics analysis (DNA, RNA, protein) and light-sheet microscopy systems such as the Papilio5D for 3D cell culture imaging. Bruker serves academia, biopharma, clinical diagnostics, and industrial markets globally. Products include handheld XRF analyzers (TITAN), bench-top vacuum FT-IR spectrometers (VERTEX NEO Ultra), nanomechanical testing systems (Hysitron PI Envision), and specialty analyzers for dairy and food quality control (MOVE-T). The company maintains significant R&D capabilities and offers comprehensive customer support services, consumables, accessories, and software through the Bruker Store. Bruker operates manufacturing and R&D facilities in Billerica, Massachusetts, and globally.

EUROIMMUN US, a subsidiary of the global leader EUROIMMUN Medizinische Labordiagnostika AG, is a manufacturer of in vitro diagnostic reagents and automation systems for clinical laboratory testing. The company specializes in immunodiagnostic assays and automated laboratory analyzers serving clinical laboratories, reference laboratories, and hospital laboratories across North America. Core product portfolios include autoimmune disease diagnostics, infectious disease serology (including viral serology for Zika, COVID-19, Oropouche, and other pathogens), allergy testing, endocrinology assays, bone metabolism markers, neurodegeneration biomarkers, and therapeutic drug monitoring. The company manufactures the IDS i20 random access chemiluminescent analyzer, AP2400 automated T-SPOT.TB testing system (FDA-approved), and distributes the ProciseDx platform. EUROIMMUN US offers training and education through its Academy and Pattern IQ learning platform for ANA pattern recognition. The company provides field service and technical support to laboratory customers. Products are designed for CLIA-certified clinical laboratories and diagnostic reference centers. The company is now part of the Revvity organization.

Applied BioCode is an in-vitro diagnostics (IVD) manufacturer specializing in cost-effective, high-throughput syndromic panel testing for infectious diseases. The company designs and commercializes multiplex molecular diagnostic systems and assays that enable clinical and research laboratories to detect multiple pathogens simultaneously. The flagship BioCode® MDx-3000 platform processes up to 188 patient samples per 8-hour shift using 96-well format automation and can run up to three different syndromic panels in parallel. Core technology includes barcoded magnetic beads for multiplex PCR amplification, hybridization, target capture, and detection. Products address respiratory infections, gastrointestinal pathogens, SARS-CoV-2, sexually transmitted infections, and fungal pathogens. The platform offers data-masking capabilities to optimize insurance reimbursement and streamline laboratory workflows by eliminating the need for multiple instruments.

Fortis Life Sciences is a strategic platform company based in Waltham, Massachusetts, founded in August 2020. It operates as a multi-subsidiary life sciences tools provider delivering specialized reagents, diagnostic components, and custom development services to biopharma, diagnostics, and research organizations globally. The company integrates five ISO 13485 certified and GMP-compliant North American manufacturing and R&D locations under its "Farm-to-Bench" system, spanning antibody discovery and production, viral vector manufacturing, nanoparticle synthesis, molecular biology reagents, and diagnostic component CDMO services. Core product portfolio includes premium monoclonal and recombinant antibodies (validated for ELISA, Western blot, IHC, flow cytometry, spatial biology), VHH domain libraries (AbNano platform), lateral flow immunoassay components, assay-grade enzymes and master mixes, diagnostic grade nanoparticles (gold, platinum, silica), and lentiviral and AAV vector production. The company also offers contract manufacturing, antibody development, spatial biology imaging services, and precision lyophilization for stable diagnostic products. It serves over 10,000 customers across biopharma, diagnostics OEMs, contract manufacturers, academic research, and applied technology sectors.

CMB Lab (Consolidated Medical Bio-Analysis, Inc.) is a full-service CLIA and CAP accredited clinical laboratory established in 1979, providing comprehensive diagnostic services to physicians, hospitals, and pharmaceutical companies. The laboratory offers routine blood analyses, HIV testing, anatomic pathology, and advanced genomic testing. CMB specializes in clinical assays and custom assay development for the pharmaceutical and biotechnology sectors, including biomarker testing and validation across Phase I–IV clinical trials. The company operates multiple patient service centers with courier service and maintains a provider web portal for results management. CMB combines clinical laboratory services with dedicated clinical trials and research capabilities, focusing on early disease detection, diagnosis optimization, and therapeutic monitoring.

Thermo Fisher Scientific is a global leader in life sciences and laboratory equipment, consumables, and digital solutions. The company manufactures and distributes a comprehensive portfolio of products for research, diagnostics, and bioprocessing applications across academic, pharmaceutical, biotechnology, and clinical laboratory markets. Product lines include transmission electron microscopes (Glacios 3 Cryo-TEM for structural biology), cell culture media and supplements (Gibco brand), molecular biology reagents (TaqMan and SuperScript PCR systems), transfection reagents (Lipofectamine), assay kits, fetal bovine serum, laboratory consumables (tubes, plates, magnetic beads), and analytical instruments. The company serves drug discovery, genomics, proteomics, cell culture, viral production, and materials analysis workflows. Thermo Fisher operates a robust e-commerce platform with online ordering of thousands of SKUs, technical support resources, interactive media selection tools, and educational content. The organization maintains ISO certifications and FDA compliance for its clinical and diagnostic products, with manufacturing facilities and distribution networks across North America and globally.

Gene by Gene is a Houston-based CLIA-certified, CAP-accredited, and COLA-accredited clinical laboratory specializing in advanced genetic testing services. Founded in 2000, the company operates as a subsidiary of myDNA Inc. and provides a comprehensive spectrum of laboratory services including whole genome sequencing (WGS), whole exome sequencing (WES), custom targeted NGS panels, SNP array analysis, Sanger sequencing, and pharmacogenomics testing. The company serves clinical practitioners, researchers, and healthcare organizations globally with rapid turnaround times and competitive pricing. Gene by Gene's in-house laboratory features robotic automation and scalable sequencing and microarray technologies. Services extend to forensic genetics (through partnership with Verogen Inc.), paternity and relationship testing, population genetics research, and biobanking. The laboratory holds permits from multiple states including California, New York, Pennsylvania, and Maryland, and is AABB-accredited for relationship testing, ensuring exceptional result accuracy and compliance with regulatory standards.

Onyvia Biolabs (formerly Prove Clinical Laboratories) is a state-of-the-art central laboratory in Sydney's CBD specialising in comprehensive clinical trial services for pharmaceutical companies, biotechs, and CROs. ISO/IEC 17025 accredited by NATA, the laboratory supports Phase I–III trials across multiple therapeutic areas with 6–8 week study startup timelines. Core capabilities include bioanalytical testing via LC-MS/MS and HPLC platforms for pharmacokinetic (PK) analysis, automated ELISA for biomarker testing, safety testing (biochemistry, haematology, coagulation, serology), histopathology with immunohistochemistry and digital imaging, flow cytometry, and PBMC isolation and storage. Additional services encompass kit assembly, sample storage across ambient and ultra-low temperature conditions (-80°C, liquid nitrogen), project management, LIMS database development, international sample logistics, site training, and vendor management. The laboratory is equipped with high-throughput, fully automated analysers and employs a team of PhD-level scientists and clinical pathologists.

Asuragen is a molecular diagnostics company specializing in genetic carrier screening and precision oncology testing. Founded in 2006 and acquired by Bio-Techne Corporation in 2021, the company develops advanced diagnostic solutions utilizing proprietary chemistries and miRNA-based technologies. Their product portfolio includes genetic testing kits for inherited disorders (Fragile X, CFTR, SMN1/2, HTT), precision oncology solutions for chronic myeloid leukemia (CML) and solid tumor monitoring, custom molecular quality controls, and armored RNA controls. The AmplideX product line encompasses PCR/CE-based assays optimized for clinical laboratories. Asuragen operates a GMP-compliant manufacturing facility and CLIA-certified laboratory, serving clinical diagnostics and research applications across oncology, genetic disorders, and carrier screening markets. The company maintains strategic partnerships and distributes products across North America and EMEA regions.

SpeeDx Pty Ltd is an Australian molecular diagnostics company specializing in multiplex PCR assays and proprietary technologies for detecting viral and bacterial infections, including antibiotic resistance markers. Founded in 2009 and headquartered in Sydney, the company develops PlexZyme®, PlexPrime®, and PlexPlus® multiplexing technologies that enable simultaneous detection of multiple diagnostic targets with high sensitivity and specificity. SpeeDx serves reference laboratories, diagnostic companies, instrument manufacturers, pharma, and biotech organizations globally. The company offers three core product lines: multiplexed IVD products for clinical diagnostics (sexually transmitted infections, respiratory, enteric panels), targeted research assays for infectious disease research, and custom development solutions. Beyond products, SpeeDx provides comprehensive partnering services including technology licensing, bespoke assay development, regulatory strategy, and manufacturing scale-up support. The company's multiplexing platform can achieve up to 12+ targets per well with unparalleled specificity for mutation differentiation, significantly reducing testing costs and time-to-result while improving laboratory efficiency across major molecular platforms.

Fort Worth Diagnostics is a cGMP-compliant assay manufacturer specializing in reagents and controls for digital PCR (dPCR) and quantitative PCR (qPCR) platforms. The company develops and manufactures bacterial, fungal, oncology, and viral controls optimized for open-system compatibility. Fort Worth Diagnostics offers both catalog and custom solutions, including probe and primer design, bioinformatics analysis, and in-process dPCR testing to ensure reproducibility. With typical turnaround times of 8 weeks for custom manufacturing and a focus on quality and customer service, the company serves molecular diagnostics laboratories, research institutions, and clinical diagnostic centers requiring validated PCR reagents and external controls.

SST International Inc. (Scientific Supplies & Technology Int'l) is a Miami-based medical and laboratory equipment distributor serving healthcare facilities, clinical laboratories, research institutions, and water testing facilities across the Caribbean, Central, and South America since 1977. The company provides access to thousands of diagnostic and laboratory products from over 150 trusted manufacturers, including hematology analyzers, immunoassay systems, PCR equipment, microbiology analyzers, and comprehensive laboratory consumables (pipettes, specimen containers, reagents, blood collection tubes). SST offers factory-trained field service engineers located across the Americas for rapid equipment service and support, specializing in point-of-care testing systems, laboratory automation solutions, and chemistry analyzers. The company serves hospitals, clinics, private and public clinical laboratories, industry quality control labs, water testing laboratories, and research institutions with reagents, consumables, chemicals, furnishings, and equipment.

Abcam is a leading life sciences company providing over 110,000 biological research products and reagents to approximately 750,000 researchers across 130+ countries. The company specializes in primary and secondary antibodies, recombinant antibodies (37,000+ offerings, including 4,900 knockout-validated variants), immunoassays, ELISA kits, proteins, peptides, gene-edited cell lines, and cellular activity assays. Abcam's product portfolio supports critical research in cancer, neurological disorders, infectious diseases, and metabolic disorders. The company is known for data-rich technical specifications, validation data, and high-citation rates among peer researchers. Abcam pioneered e-commerce and data-sharing platforms in life sciences, streamlining antibody and reagent sourcing for academic and pharmaceutical research. Recent innovations include SimpleStep Ignite™ ELISA kits offering 50x greater sensitivity, MollAI AI-powered product recommendation tools, and trial-size antibody offerings to reduce research costs and validation risk.

umedwings is a B2B medical device distributor and supply aggregator that facilitates direct ordering from multiple medical device manufacturers. The platform curates and distributes a broad range of medical equipment including diagnostic instruments (PCR kits, blood gas and electrolyte analyzers), patient monitoring systems (multiparameter monitors, ECG machines), intensive care equipment (ICU ventilators, infusion pumps, defibrillators), ultrasound diagnostic systems, anesthesia machines, oxygen delivery systems, and hospital furniture. The company serves healthcare facilities and veterinary clinics, offering products from numerous OEM partners including Bioperfectus, Cornley, Dartmon, Biolight, Northern Medical, EMP, and Wisonic. This B2B marketplace model enables hospitals and clinics to access manufacturing-direct pricing on essential medical equipment without intermediary markups.

ZeptoMetrix is a leading biotechnology company specializing in quality controls, assay development services, analytical reference materials, and proficiency testing for infectious disease diagnostics and analytical markets. Founded in 1999 and headquartered in Buffalo, New York, the company operates as a division of Antylia Scientific. ZeptoMetrix serves diagnostic microbiology, oncology, environmental testing, food & agriculture, cannabis & hemp, and pharmaceutical sectors. The company offers molecular controls for diagnostic testing, analytical reference materials including certified reference materials (CRMs) for environmental contaminants (PFAS, microplastics, pesticides, organotins), food safety standards, cannabis potency testing compounds, and pharmaceutical reference standards. ZeptoMetrix provides ISO 17043-accredited proficiency testing programs, viral lysates and culture fluids, seroconversion panels, monoclonal and polyclonal antibodies, ELISA kits, microbiological controls, and oncology molecular controls. With approximately 106-200 employees and ~$10M annual revenue, ZeptoMetrix serves global customers through direct sales and distributor networks, supported by comprehensive technical documentation and regulatory compliance resources.

Medical & Biological Laboratories Co., Ltd. (MBL) is Japan's leading research reagent and diagnostic supplier, established in 1969. As the nation's first antibody manufacturer, MBL specializes in high-quality research reagents, diagnostic reagents, and customized companion diagnostics for clinical laboratories, hospitals, and life science researchers globally. The company operates R&D facilities in Nagano and Ibaraki, with a distribution center in Chiba. MBL's extensive product portfolio encompasses monoclonal and polyclonal antibodies, MHC tetramers, organoid growth factors, epitope tags, cell culture reagents, flow cytometry reagents, magnetic particles, latex particles, and specialized research tools across immunology, cancer research, autoimmune disease diagnostics, epigenetics, neuroscience, and drug discovery. Key branded product lines include CycLex, CircuLex, CoralHue™, HRP-DirecT, RiboCluster Profiler™, IMMUTEX™, and Magnosphere™. MBL supplies both research-use-only (RUO) and in vitro diagnostic (IVD) products to academic institutions and clinical diagnostics centers worldwide.

Lighthouse Lab Services is a Charlotte, North Carolina–based full-service medical laboratory consulting, recruiting, and operational solutions firm. Founded in 2003 and expanded through strategic acquisitions including Elite Diagnostics (2019), the company serves as a comprehensive partner for laboratory startup, compliance, staffing, and operations management. Services include CLIA/COLA/CAP certification and compliance support, laboratory startup and design, specialized recruiting and medical director placement (serving 200+ CLIA-accredited labs nationwide), equipment procurement and instrument servicing with OEM components and FDA-certified engineers, test validation, quality management, revenue cycle management and payer contracting, LIS software solutions (Beacon LIS platform), and specialized molecular and toxicology laboratory solutions. The company specializes in infectious disease, pathology, molecular diagnostics, toxicology, and cytology. With a team of 150+ experts managing and supporting hundreds of laboratories across the United States, Lighthouse positions itself as the nation's largest dedicated medical laboratory consulting and recruiting firm.

Magnet Medical Systems (MMS) is a leading laboratory and diagnostic supply company specializing in advanced consumables and reagent kits for clinical diagnostics and molecular pathology. The company offers a comprehensive portfolio including automation-ready pipette tips, laboratory plastics, and disposables designed for precision and cost-effectiveness across diverse laboratory environments. MMS provides rapid nucleic acid extraction solutions (SPEEDEX ULTRA™) enabling extraction in under 15 minutes for various sample types including saliva, nasal swabs, urine, and blood. Their M2Max Ultra Nucleic Acid Extraction Kits support processing from 1 to 96 samples with streamlined workflows. Additionally, MMS manufactures PCR reagent kits for high-throughput detection of respiratory pathogens (SARS-CoV-2, influenza A/B, RSV A/B) and sexually transmitted infections, with up to 400 reactions per kit and sub-45-minute run times. The company emphasizes building lasting partnerships through exceptional performance and value-driven supply solutions.

NuWav Labs is a CLIA-certified, COLA-accredited clinical laboratory offering comprehensive diagnostic solutions including core laboratory testing (chemistry, hematology, immunology), molecular diagnostics (COVID-19, Flu A/B, RSV), and high-quality reagents and kits for healthcare providers and diagnostic laboratories. The company specializes in fast turnaround times with 99% accuracy across 500+ test types, operating under HIPAA compliance and federal regulatory standards. NuWav serves as a scalable diagnostic partner for hospitals, clinics, and research institutions requiring reliable laboratory testing and reagent supply.

Enable Biosciences is a South San Francisco-based diagnostics company spun out of UC Berkeley and Stanford in 2016. The company develops ultrasensitive immunoassays for early detection and risk stratification of autoimmune and infectious diseases, with particular expertise in Type 1 Diabetes autoantibody screening and detection. Their ADAP (Advanced Diagnostics for Autoimmune Prediction) technology platform enables predictive medicine through proprietary whole blood autoantibody detection methods. The company partners with leading institutions including Stanford Healthcare, Harvard Medical School, California Department of Public Health, and JDRF, and has performed over 150,000 tests to date. Enable Biosciences' assays support early intervention and clinical decision-making for diabetes risk prediction and population-based screening programs.

Dompé farmaceutici S.p.A. is an international biopharmaceutical company headquartered in Milan, Italy, with 130+ years of history. The company operates across the full pharmaceutical value chain—research, development, manufacturing, and commercialization—specializing in primary care drugs and biotechnology targeting unmet medical needs. Key therapeutic focus areas include ophthalmic diseases (particularly rare degenerative conditions), neurological disorders, pain management, anti-inflammatory treatments, and oncology. Dompé is recognized for developing the first recombinant human Nerve Growth Factor (rhNGF) treatment, a breakthrough for rare eye diseases. The company maintains a robust R&D infrastructure with facilities in L'Aquila and collaborations with major partners including Amgen and Biogen. With ~819 employees and 2024 revenues around €268.5 million, Dompé combines family heritage with modern biotech innovation, leveraging proprietary platforms like Exscalate (AI-powered virtual drug screening) and advanced clinical trial capabilities to accelerate therapeutic discovery and market introduction across multiple indication areas.

ARUP Laboratories is a national, academic, nonprofit reference laboratory established in 1984 as part of the University of Utah's Department of Pathology. Operating 65 highly automated laboratory facilities with 4,300 employees, ARUP serves healthcare providers nationwide with over 3,000 diagnostic tests. The laboratory maintains a two-story freezer capable of storing 2.3 million specimens and provides industry-leading turnaround times. ARUP's test menu encompasses genetics, molecular oncology, pediatrics, neurology, hematopathology, and infectious disease testing. Beyond core laboratory services, ARUP offers comprehensive consulting through its Healthcare Advisory Services division, addressing laboratory stewardship, operations optimization, outreach planning, and data analytics. The company maintains a robust research and innovation program through its Institute for Research and Innovation in Diagnostic and Precision Medicine, supporting clinical trials, pharmaceutical companion diagnostics, and academic research initiatives. ARUP provides ARUP Consult®, a clinical decision support resource featuring testing algorithms and expert insights, alongside continuing education for laboratory professionals. CAP-, CLIA-, and ISO 15189-accredited, ARUP serves academic medical centers, children's hospitals, government facilities, and healthcare systems across the U.S.

Key Scientific Products is a long-established distributor and manufacturer of microbiology and laboratory diagnostics supplies, serving clinical and research laboratories since 1935. The company specializes in a comprehensive portfolio of chromogenic bacterial identification tests, organism preservation systems (Cryocare), and rapid identification products (Identicult AE, LAP, PRO) for gram-negative, gram-positive, and anaerobic bacteria. Key Scientific offers a broad range of laboratory consumables including culture media, antisera, antibiotic/sensitivity discs, microscope slides and accessories, mycobacteria and mycology products, parasitology reagents, and stains. The product line encompasses both proprietary formulations and distributed brands (Rosco Diagnostica, Hardy Diagnostic, Denka Seiken, Scientific Device Labs, Medical Chemical Co), serving hospital laboratories, reference laboratories, and research institutions.

RPI Biosolutions is a B2B supplier of biochemicals, growth media, molecular biology reagents, and laboratory equipment for research institutions and clinical laboratories. The company provides amino acids, agarose, buffers (including PBS solutions), electrophoresis reagents, antibiotics, enzymes (IPTG), and microbial culture media (LB agar, yeast extract, terrific broth). Product offerings also include laboratory instruments such as centrifuges, precision balances, and sample handling supplies (tubes, racks, labels, microscope slides). RPI is committed to sustainability practices and offers special programs including discounts for new or relocating laboratories. The company serves academic research, biotechnology, pharmaceutical, and diagnostic sectors.

Clear Labs is a genomics testing company specializing in fully automated next-generation sequencing (NGS) platforms for clinical diagnostics, food safety, and research applications. The company delivers end-to-end solutions integrating robotic automation, genomic sequencing, and bioinformatics software for pathogen detection, infectious disease surveillance, and oncology research. Clear Labs offers clinical diagnostic solutions for rapid bacterial and fungal identification from sterile specimens, whole genome sequencing for microbial surveillance, and food safety testing platforms (Clear Safety™) for Salmonella and Listeria detection and serotyping. Research-use-only platforms include Clear Dx® for oncology NGS workflows and Clear Ix™ for infectious disease sequencing. The company serves clinical laboratories, food safety operations, and research institutions, providing actionable molecular insights to reduce foodborne illness outbreaks and accelerate infectious disease and cancer genomics research.

LabTurbo Biotech Corporation is a molecular diagnostics and laboratory automation company specializing in fully automated nucleic acid extraction and qPCR solutions for high-complexity laboratories and healthcare providers. The company manufactures integrated and standalone extraction/qPCR platforms alongside consumable kits (DNA/RNA extraction, PCR panels) designed for high-throughput, hands-off workflows. LabTurbo serves clinical laboratories with rapid PCR diagnostic testing panels targeting COVID-19, influenza, RSV, respiratory pathogens, UTI, STD, gastrointestinal, and pharmacogenomics (PGx) applications. The product portfolio includes fully automated systems (AIO 48 SP-qPCR, 48 Extraction System, QuadAIO point-of-care), manual extraction platforms (VacEZor), and validated consumable kits. The company has received recognition including the 2022 Biotech Industry Award and National Innovation Award for excellence in automated gene testing and nucleic acid detection.

Hamilton Company is a global manufacturer of precision liquid handling equipment and process analytics solutions for life sciences research and bioprocessing. Founded in the late 1940s and headquartered in Reno, Nevada, with European operations in Bonaduz, Switzerland, Hamilton specializes in microliter syringes, automated liquid handling systems, sample storage solutions, and in-line process monitoring sensors. The company serves pharmaceutical, biotechnology, genomics, cell therapy, and analytical chemistry sectors with products ranging from hand-fitted manual syringes to fully integrated robotic automation platforms. Hamilton's solutions support critical workflows including NGS library preparation, cell culture, bioprocess monitoring, compound handling, and high-throughput screening. The company emphasizes application-specific customization, field service support, and training programs to enable seamless workflow integration across benchtop and production-scale operations.

MP Biomedicals is a global life science company founded in 1959 and headquartered in Irvine, California. The company develops, manufactures, and distributes over 55,000 products, including life science reagents, fine chemicals, in vitro diagnostics, and dosimetry tools. It serves a wide range of researchers, from those in basic research to full-scale production. As a wholly-owned subsidiary of Valiant Co., Ltd., MP Biomedicals operates ISO-certified and FDA-approved facilities worldwide. The company employs between 533 and 827 people and has reported annual revenues ranging from $87.5 million to $279.2 million. Its product portfolio includes reagents for research, large-scale fine chemicals, diagnostic tools like monoclonal antibodies and ELISA kits, specialized dosimetry products, sample preparation systems, nucleic acid extraction kits, cell culture media, mycoplasma control solutions, and laboratory automation instruments. MP Biomedicals is committed to supporting scientific discovery in biotechnology and diagnostics, catering to the needs of scientists and organizations in these fields.

Savyon Diagnostics is an Israeli in vitro diagnostics company founded in 1984, specializing in developing, manufacturing, and marketing high-quality diagnostic test systems. The company focuses on infectious disease diagnosis and genetic screening with over 100 different test markers. Savyon employs multiple diagnostic techniques including ELISA, Microimmunofluorescence, Immunoprecipitation Assay, immunochromatographic rapid kits, and DNA/RNA Micro Arrays. The NanoCHIP platform is a key innovation—an automated instrument for high-throughput multi-analyte molecular testing used in clinical microbiology, genetics, and pathology laboratories. Beyond clinical diagnostics, Savyon offers contract development and manufacturing services for biotech companies, genetic and molecular lab services, and GMP-certified analytical services for pharmaceutical companies and research institutes. The company serves clinical laboratories, point-of-care settings, and home-use diagnostic markets, with recent expansion into consumer-facing products such as Savvycheck, a self-testing kit for vaginal yeast infection diagnosis.

Biodesix is a CLIA-certified and CAP-accredited life sciences diagnostics company specializing in AI-driven, blood-based diagnostic tests for lung cancer and related respiratory diseases. Founded in 2005 and publicly traded since 2020, the company combines multi-omic approaches—including genomics, proteomics, and advanced mass spectrometry—with proprietary artificial intelligence algorithms to deliver personalized diagnostic solutions. Flagship offerings include the Nodify Lung Nodule Risk Assessment and IQLung Strategy Tests, which guide clinical decision-making for lung nodule management and non-small cell lung cancer treatment selection. Beyond clinical diagnostics, Biodesix operates a robust biopharma services division providing translational research, biomarker discovery, companion diagnostic development, and clinical trial support to leading biopharmaceutical and research institutions. The company's liquid biopsy technology platform enables non-invasive risk stratification and prognostic assessment, addressing a critical clinical need in early cancer detection and precision oncology.

Advanced Cell Diagnostics (ACD), a Bio-Techne brand, specializes in molecular pathology and spatial biology solutions for research, drug development, and precision medicine. The company is renowned for its proprietary RNAscope® in situ hybridization (ISH) technology, which enables precise RNA biomarker analysis at single-molecule resolution within preserved tissue and cellular morphology. ACD's extensive product portfolio—including over 9,000 offerings—encompasses RNAscope™ assays (standard, multiplex fluorescent, and HiPlex versions), BaseScope™ assays for DNA and splice variant detection, miRNAscope™ for microRNA analysis, DNAscope™ for chromogenic DNA detection, and RNA-protein co-detection assays for spatial multiomics. The company also provides Professional Assay Services (PAS) for custom probe development and high-throughput biomarker analysis supporting applications in immuno-oncology, gene therapy, drug safety assessment, and patient-derived xenograft (PDX) characterization. With headquarters in Newark, CA, and global operations in the UK and China, ACD serves academic institutions, pharmaceutical companies, and contract research organizations worldwide.

Gold Standard Diagnostics (GSD) is a global diagnostic solutions provider headquartered in Dietzenbach, Germany, specializing in the development, manufacturing, and commercialization of diagnostic test kits, reagents, instruments, and automation systems. Formed through strategic mergers including Virotech Diagnostics and Novatec Immunodiagnostica, GSD serves clinical, food, feed, environmental, biopharma, veterinary, and animal health sectors. The company offers comprehensive diagnostic workflows including ELISA test kits, PCR assays, lateral flow devices, and automated platforms for virology, bacteriology, oncology, allergen detection, food pathogen identification, and mycotoxin analysis. GSD provides magnetic separation solutions, culture media, sampling devices, and reference materials. All products emphasize quality and compliance with CE-IVD marking under EU regulations. Services include antibody development, technical support, and training for laboratories, healthcare professionals, and research institutions.

LEX Diagnostics Limited (now acquired by QuidelOrtho) is a molecular diagnostics company specializing in ultra-fast point-of-care PCR testing platforms. Based in Melbourn, United Kingdom, the company develops the LEX VELO system, a CLIA-waived compact PCR molecular diagnostics platform designed for decentralized healthcare settings including physician offices, urgent care centers, pharmacies, and hospitals. The LEX VELO system delivers lab-quality results with minimal hands-on time (less than one minute), reporting positive results in as little as six minutes and negative results in under ten minutes. The current test menu includes multiplex detection and differentiation of Influenza A, Influenza B, and COVID-19, with planned expansion to include Strep A, RSV, and STIs. The system features a fully automated swab-to-result workflow with no swab elution or liquid sample handling required, significantly reducing infection risk and operational complexity in point-of-care settings.

Genesystem Co., Ltd. is a South Korean biotech engineering company specializing in point-of-care molecular diagnostic solutions. The company develops rapid PCR-based testing platforms utilizing proprietary biochip and ultra-fast PCR technologies for on-site molecular diagnostics. Primary product lines include the UF-series instruments (UF-300, UF-340, UF-100, UF-150) designed for rapid DNA amplification and qPCR applications, complemented by consumables including Rapi:chip cartridges, PCR reagents optimized for ultra-fast performance, and nucleic acid extraction kits. Assay portfolio spans human pathogen detection (SARS-CoV-2, influenza, RSV, tuberculosis, HPV, STIs), veterinary diagnostics (canine and feline disease panels for skin, respiratory, gastrointestinal, and neurological conditions; livestock diagnostics for ASFV, SBV, FMDV), and food safety applications (foodborne pathogen detection, halal assurance, meat authentication). The company emphasizes multiplex capability, rapid sample-to-result turnaround (20-minute DNA amplification), and miniaturized heating module technology. Genesystem exhibits internationally at major diagnostic conferences (MEDICA, AACC, IFCC) and maintains a global network of distributors. Manufacturing and R&D focus on biochip-based multiplex POCT solutions with expansion into biomarker development and diversified multiplex diagnostic applications.

Tecan Group AG is a global life sciences and diagnostics company specializing in laboratory automation, microplate readers, microplate washers, liquid handling systems, and molecular diagnostics solutions. The company serves research institutions, clinical laboratories, and diagnostic centers with a comprehensive portfolio of hardware platforms, reagents, software, and custom automation solutions. Key product lines include the Fluent® and Veya® laboratory automation workstations, Freedom EVO® platform, microplate readers (Spark®, Infinite® series, Sunrise™), and microplate washers (HydroFlex™, HydroSpeed™). The diagnostics division provides mass spectrometry sample preparation systems, positive pressure workstations (Resolvex), and pre/post-analytical automation solutions. Tecan also manufactures next-generation sequencing (NGS) library prep reagents and consumables under brands including Celero, Revelo, and Ultralow DNA-Seq kits. The company's software offerings (FluentControl™, Freedom EVOware®, Magellan™, i-control™, Introspect™) support workflow automation and data management across genomics, proteomics, immunoassay, and clinical diagnostics applications. Manufacturing and OEM partnering services through the Partnering division include liquid handling components, robotic technologies (Cavro systems), and contract manufacturing capabilities. Tecan maintains ISO 13485 quality certification and operates globally with headquarters in Switzerland and significant operations in the US, Europe, and Asia-Pacific. Products are marketed to pharmaceutical research, biotech, clinical laboratories, and diagnostic service providers.

REAGEN, INC. is a global biotechnology company specializing in in vitro diagnostics (IVD), molecular diagnostics, and rapid testing solutions. The company manufactures and distributes ELISA test kits, colloidal gold immunochromatography strips, PCR test kits, rapid antigen detection kits, and raw materials for antigen and antibody production. Product portfolio includes multi-pathogen respiratory antigen rapid tests (4-in-1, 6-in-1, 10-in-1 formats), infectious disease serology kits (Measles IgG/IgM, Neisseria meningitidis), pregnancy hormone (HCG) tests, drug abuse screening panels, and food safety testing solutions. The company also serves veterinary diagnostics and animal health markets. REAGEN operates with proprietary core technology and maintains CE certifications; distributed across 140+ countries with established relationships with major retail and healthcare partners including Walgreens and hospital chains. Manufacturing capabilities include latex microsphere-based strip technology and rapid field-deployable test formats requiring no special equipment or training. Typical turnaround for global orders is under two weeks. The company emphasizes batch consistency, complete regulatory documentation, and on-site technical support services.

Sartorius is a global life sciences company founded in 1870, specializing in bioprocess solutions, laboratory instrumentation, and technologies for biopharmaceutical research and manufacturing. The company provides an integrated portfolio spanning from lab-scale research to large-scale medication manufacturing, including single-use bioprocess systems, bioreactors and fermenters, process filtration and chromatography, cell culture media, weighing and pipetting instruments, process analytical technology (PAT), live-cell imaging systems, and water purification solutions. Sartorius serves pharmaceutical companies, researchers, and biotech manufacturers with mission-critical tools for drug development, cell therapy manufacturing, and bioprocess optimization. The company operates globally with ~14,000 employees and generates approximately €3.5 billion in annual revenue, committed to advancing biopharmaceutical innovation and sustainable manufacturing practices.

Cepheid is a molecular diagnostics company specializing in rapid, point-of-care testing systems and molecular assays. The company's flagship GeneXpert® System is a fully scalable platform offering a broad menu of diagnostic tests across infectious disease, respiratory health, gastrointestinal disorders, and other clinical areas. Their platform serves settings from core laboratories to near-patient and point-of-care applications, enabling fast turnaround results for improved clinical decision-making. Cepheid's test portfolio includes PCR-based assays for tuberculosis, respiratory infections, gastrointestinal pathogens, and healthcare-associated infections. The company markets solutions to laboratory professionals, healthcare providers, and health system administrators. Cepheid operates a Global Access Program focused on expanding diagnostic access in underserved and resource-limited regions, including support for cervical cancer screening and TB elimination initiatives. Products are designed for workflow connectivity and integration within healthcare settings. The company emphasizes rapid, accurate diagnostic results to support effective patient management and antimicrobial stewardship. Manufacturing and regulatory compliance are implied through FDA and international certifications typical of molecular diagnostic systems.

QIAGEN is a multinational life sciences company specializing in sample preparation, nucleic acid purification, and molecular diagnostic technologies. The company offers comprehensive solutions including consumable kits for DNA/RNA extraction, automation systems for sample processing, and advanced diagnostic platforms utilizing PCR, digital PCR (dPCR), and next-generation sequencing (NGS). QIAGEN serves diverse markets including clinical laboratories, pharmaceutical and biotech companies, academic research institutions, and organizations in forensics, food safety, and pathogen surveillance. The company provides integrated solutions spanning discovery and translational research, diagnostics and clinical research, human ID and forensics applications, and informatics and data analysis. With over 500,000 customers globally, QIAGEN delivers end-to-end workflows under its "Sample to Insight" philosophy, combining instruments, consumables, and software platforms for molecular testing and biomarker discovery.

altona Diagnostics is a medical diagnostics company specializing in the development, manufacture, and distribution of in vitro diagnostic (IVD) test solutions based on polymerase chain reaction (PCR) technology. The company designs and sells assays for the detection of pathogens including viruses, bacteria, and parasites. Product portfolio includes the AltoStar® line of RT-PCR kits and related diagnostic solutions, with recent offerings in HDV (Hepatitis Delta Virus) detection, transplant diagnostics, and multiplex assays (e.g., Chikungunya, Dengue, Zika triplex). altona Diagnostics also provides automation solutions and analytical software (AltoStar® Analysis) to support laboratory workflows. The company maintains CE-IVD and IVDR compliance certifications for its assay portfolio. Operations are headquartered in Hamburg, Germany, with a USA subsidiary presence. The company serves clinical laboratories, diagnostic reference centers, and transplant institutions requiring pathogen detection capabilities and supports both research and routine clinical diagnostics applications.

Agena Bioscience manufactures the MassARRAY System, a mass spectrometry-based platform for genetic analysis and molecular diagnostics. The company specializes in multiplexed SNP genotyping, mutation detection, and biomarker analysis across multiple clinical and research applications. Primary product lines include pharmacogenetics (PGx) panels such as the VeriDose Core PGx Panel and VeriDose DPYD Plus Panel, oncology mutation profiling panels (lung, colon, melanoma, EGFR), hereditary genetics panels (CFTR 100+, HFE), and custom assay design services. The MassARRAY platform enables liquid biopsy, sample integrity testing, methylation analysis, and specimen validity assessment. Applications span pharmacogenomics, tumor profiling, hereditary disease screening, and precision medicine workflows. Agena operates global distribution through certified service providers and maintains direct sales and support infrastructure across North America, Europe, Asia Pacific, and China. The company provides comprehensive laboratory testing services via Assays by Agena, service plans, and customer support through a dedicated portal. Platform strengths include minimal bioinformatics requirements, broad multiplexing capabilities, cost-effective workflow integration, and compatibility with formalin-fixed paraffin-embedded (FFPE) samples.

Grifols Diagnostic Solutions is a global leader in transfusion medicine diagnostics and clinical laboratory testing, serving blood banks, hospital transfusion centers, and clinical laboratories. The company manufactures and markets a comprehensive portfolio of donor screening and typing solutions, patient testing systems, and clinical diagnostic instruments. In donor testing, Grifols offers the Procleix Panther and Procleix Xpress systems for nucleic acid testing (NAT) with multiple assays including Ultrio Elite, Babesia, HEV, Parvo/HAV, Plasmodium, and arbovirus panels. For patient testing, the company provides HELIOS and HELIA automated immunoassay systems for autoimmunity testing (IFA and immunoblot), the Chorus Trio instrument for infectious disease diagnostics, and genotyping solutions. Grifols also supplies biological drug monitoring systems (Promonitor), SARS-CoV-2 serology assays, and A1AT genotyping tests. Supporting these instruments are integrated software solutions including Procleix NAT Manager, Bloodstream, and HERA middleware for laboratory workflow management. The company emphasizes laboratory efficiency, turnaround time reduction, and reliability. Grifols provides comprehensive support services including technical support, maintenance, calibration, training, and consulting through its FlexLab program. The organization maintains sophisticated cybersecurity protocols and pursues sustainability initiatives. Grifols has a longstanding history spanning over a century in diagnostic innovation and serves healthcare systems globally with regulatory clearances for US and international markets.

Eppendorf SE is a global laboratory equipment manufacturer headquartered in Germany with North American operations in Enfield, Connecticut. The company designs and manufactures premium scientific instrumentation and consumables for research, clinical, and bioprocess laboratories. Core product lines include pipetting systems (manual and automated), centrifuges (multipurpose and ultracentrifuges), PCR thermocyclers, cell culture incubators with CO₂ control, temperature control and mixing devices, lab shakers, cold storage units (refrigerators and freezers), and bioprocess solutions. Eppendorf also supplies laboratory consumables including pipette tips, tubes, and related disposables. The company provides comprehensive customer support including preventive maintenance, calibration, certification, qualification services, and repair for discontinued products. Digital offerings include myEppendorf account management, a service portal for device management, and digital lab management solutions. Eppendorf serves academic research institutions, pharmaceutical companies, biotechnology firms, clinical laboratories, and contract research organizations worldwide. The company emphasizes ergonomic design, connectivity, compliance capabilities, and sustainability in its product development.

ALPCO (American Laboratory Products Company, Ltd.) is a global in vitro diagnostics (IVD) and research-use-only (RUO) company headquartered in Salem, New Hampshire. Founded in 1991 as an immunoassay importer and distributor, ALPCO has evolved into a leading producer of immunodiagnostic reagents and molecular diagnostics solutions. Following its April 2022 merger with GeneProof, the company enhanced its capabilities in PCR technologies for infectious disease and genetic mutation detection. ALPCO specializes in high-sensitivity immunodiagnostic assays, real-time PCR kits, and multiplex allergy assays with applications across gastroenterology, autoimmune conditions, metabolic disorders, and infectious diseases. The company offers automated sample-to-answer platforms and chemiluminescence-based immunoassays (ELISA, immunoturbidimetric), emphasizing workflow efficiency and supporting clinical laboratories and research facilities globally.

Meridian Bioscience is a leading manufacturer of molecular and immunological reagents for diagnostic applications, operating through two primary divisions: Life Science and Diagnostics. The Life Science division develops reagents, antibodies, and molecular biology products for research and discovery applications, including lyophilized DNA fragmentation kits and NGS (next-generation sequencing) portfolio items. The Diagnostics division manufactures best-in-class diagnostic platforms, assays, and tests with comprehensive customer education and technical support. The company serves clinical laboratories, research institutions, and healthcare providers globally with products spanning from discovery phase through clinical diagnosis. Meridian maintains ISO and regulatory compliance across its product lines and operates manufacturing and service facilities in the United States (Cincinnati headquarters and Memphis Life Science facility), Canada, China, Germany, Israel, Italy, and the United Kingdom. The company provides technical support through dedicated customer service teams for both divisions, including diagnostic technical services and product support centers. Meridian's operations encompass reagent manufacturing, diagnostic platform development, and comprehensive laboratory support services.

Takara Bio USA, Inc. is a research tools and reagent supplier providing kits, reagents, instruments, and services for gene discovery, regulation, and function studies. The company operates as part of the Takara Bio Group, a global leader in biotechnology. Core product lines include next-generation sequencing (NGS) platforms such as Shasta single-cell systems and spatial omics solutions (Trekker and Seeker); real-time PCR instruments including SmartChip ND high-throughput qPCR systems; nucleic acid purification kits (plasmid, genomic DNA, and RNA); PCR polymerases and master mixes; cDNA and mRNA synthesis reagents; cloning solutions (In-Fusion seamless cloning); stem cell research media and differentiation kits; gene editing and viral transduction products; protein purification systems; and antibodies and ELISA assays. The company also offers custom enzyme OEM services under ISO 13485:2016 certification, automated liquid handling integration partnerships, certified service provider programs for NGS workflows, and gene and cell therapy manufacturing services. Applications span molecular diagnostics, mRNA and protein therapeutics, pathogen detection, immunotherapy research, cancer research, and reproductive health. Products are marketed under the Clontech, TaKaRa, and Cellartis brand portfolios. The company serves academic research institutions, biotech firms, and clinical diagnostic laboratories globally.

Co-Diagnostics, Inc. is a molecular diagnostics company specializing in real-time PCR (polymerase chain reaction) testing platforms and assays for infectious disease detection. The company develops and manufactures PCR instruments, test kits, and diagnostic solutions for clinical, research, and vector control applications. Core product lines include the Co-Dx PCR Pro platform (an on-site PCR instrument for point-of-care and home testing), the Co-Dx Box (a compact qPCR cycler), and the Logix Smart® assay line covering COVID-19, tuberculosis, influenza, RSV, HPV, and other infectious diseases. Co-Dx also offers research-use-only (RUO) products for laboratory applications and specialized Vector Smart™ PCR tests for mosquito abatement and vector control professionals. The company markets its solutions to at-home consumers, healthcare providers, clinical laboratories, enterprises, and vector control agencies. Technology differentiators include proprietary Co-Primers® technology (which reduces primer dimer propagation) and multiplex PCR capabilities enabling simultaneous detection of multiple pathogens. Products are available as FDA-cleared or Emergency Use Authorized (EUA) in vitro diagnostics (IVD) where regulatory approvals have been obtained. The company maintains ISO 13485:2016 certification for quality management systems.

Eurofins Viracor is a specialty clinical diagnostic laboratory with over 40 years of expertise serving critically ill and immunocompromised patients. The company operates a CAP-accredited, CLIA-certified laboratory offering a comprehensive menu of nearly 3,000 assays across infectious disease, transplant diagnostics, immunology, allergy/hypersensitivity, and fungal pathology. Specializations include next-generation sequencing (NGS) for pathogen detection, CAR T-cell therapy monitoring (ExPeCT™ assays), and molecular diagnostics for immunocompromised populations. Known for rapid turnaround times (8–12 hours for infectious disease testing from specimen receipt), Eurofins Viracor serves 75% of U.S. transplant programs and provides both routine and complex custom assay development for clinical research and biopharmaceutical applications.

Boca Scientific Inc is a premier distributor of advanced biotechnology reagents, kits, and laboratory supplies for research institutions across the United States and Canada. The company curates a specialized selection of molecular biology, immunology, cell biology, and diagnostic products sourced from leading manufacturers in Europe, Asia, and the Americas. Product offerings encompass DNA polymerases, PCR reagents, cell culture media, transfection reagents, DNA/RNA purification and isolation kits, antibodies, protein markers, immunoassay optimization reagents, western blotting supplies, vector systems, freezer storage solutions, and laboratory instrumentation. Boca Scientific serves academic research labs, biotech firms, and diagnostic laboratories with high-quality consumables and equipment supporting genomics, cell biology, and molecular research workflows.

Four E's Scientific (Four E's USA) is a global manufacturer and original equipment manufacturer (OEM) of laboratory equipment and medical devices serving North America. The company specializes in designing and building high-quality laboratory instruments focused on mixing, heating, cooling, and liquid handling. Core product categories include pipetting systems (Per4mance® and Precipette™ lines with ISO 8655 calibration and fully autoclavable designs), water baths (2–24 liter models, digital and stainless steel variants), rotary evaporators, PCR systems (OptimaFlex multi-block gradient), nucleic acid extraction platforms (MultiEX series with 16–96 throughput capacity), fluorometers (FLR200HS), micro-volume spectrophotometers, vortex mixers, centrifuges, magnetic stirrers, and histology-related equipment including paraffin wax trimmers and UV histology printers for microscope slide and tissue cassette marking. The company maintains over 100 engineers dedicated to product design and customer support. Four E's operates as both a direct seller and a private-label manufacturer, supplying hundreds of commercial partners with custom and white-label equipment. Markets served include pharmaceutical, industrial, blood banking, research, diagnostics, medical, environmental, and food and beverage sectors. The company markets its products as ergonomic, accurate, and precise, with particular emphasis on autoclavable laboratory consumables and sample-handling instrumentation.

Shimadzu Medical Systems is a division of Shimadzu Corporation, a Japanese precision instruments and analytical equipment manufacturer founded in 1875. The medical systems segment specializes in diagnostic imaging equipment, particularly advanced X-ray and fluoroscopic systems. Shimadzu manufactures mobile C-arm systems, floor-mounted radiography units with auto-tracking capabilities, mobile X-ray systems, angiography equipment, and fluorescence imaging solutions. The company is recognized for pioneering innovations in medical imaging, including Japan's first medical X-ray device, the world's first remote-controlled X-ray TV system, and fully digital mobile X-ray platforms. These diagnostic imaging systems are designed to support early disease detection and treatment across clinical and hospital settings. Shimadzu also supplies analytical instruments for life science laboratories, including chromatography systems, mass spectrometry equipment, and sample handling solutions, serving pharmaceutical research, clinical diagnostics, and healthcare facilities globally.

Genetic Signatures Limited is a molecular diagnostics company specializing in the development and commercialization of proprietary real-time PCR-based detection systems for infectious disease screening. The company's core platform, 3base™, utilizes streamlined sample processing methods linked to highly multiplexed real-time PCR assays to simultaneously detect multiple pathogen targets faster than conventional methods. Primary product line includes the EasyScreen™ brand of detection kits, which employ DNA methylation pattern identification and sequence simplification technology. The company has achieved FDA 510(k) clearance for the EasyScreen™ Gastrointestinal Parasite Detection Kit, now distributed through leading US clinical laboratories. Additional offerings include Analyte Specific Reagents (ASRs) for laboratory-developed test applications. Genetic Signatures serves clinical laboratories, diagnostic facilities, and healthcare systems requiring rapid, multiplexed infectious disease identification. The company maintains regulatory compliance with FDA standards and positions itself as a specialist in molecular diagnostics innovation, with particular expertise in gastrointestinal parasite and pathogen detection. Operations span both US and international markets, with documented presence in the US healthcare diagnostics sector.

Werfen (formerly Immucor, Inc.) is a global leader in specialized diagnostics for transfusion and transplantation medicine. The company manufactures a comprehensive portfolio of serology-based reagents, automated instruments, and molecular diagnostic products serving blood banks, transfusion services, clinical laboratories, reference laboratories, donor centers, and transplant programs worldwide. Core product lines include: (1) Transfusion diagnostics—blood typing, antibody screening and identification, platelet serology, and HLA donor screening assays; (2) Transplant diagnostics—HLA typing kits (including NanoTYPE® HLA-11 Plus), HLA and non-HLA antibody detection products, and post-transplant monitoring assays; and (3) Coagulation diagnostics for heparin-induced thrombocytopenia (HIT) and thrombotic thrombocytopenic purpura (TTP) detection. Signature automated platforms include the NEO® and NEO Iris® systems for immunohematology automation, and Echo Lumena® for antibody identification with enhanced imaging. The company acquired Omixon (Hungary) to expand HLA typing capabilities. Werfen operates globally across hospital blood banks, reference laboratories, and transplant centers, leveraging customer-centric support with field representatives who possess transfusion and transplant technical expertise. The company emphasizes regulatory compliance, quality assurance, and comprehensive technical and educational support to streamline laboratory workflows and improve patient outcomes in transfusion and transplant medicine.

Biomiga, Inc. is a San Diego-based biotech research and manufacturing company specializing in nucleic acid extraction, purification, and PCR-based diagnostic products. Core product lines include the MgPure family of automated DNA/RNA extraction kits designed for diverse sample types: pathogenic, blood, saliva, circulating cell-free DNA, and formalin-fixed paraffin-embedded (FFPE) tissue. The company manufactures DNA/RNA size-selection beads offering superior yield (10–20% better than benchmarks) at competitive pricing, with full USA manufacturing and OEM customization capability. MgPure Seq DTR beads support sequencing workflows with >800 bp average reading lengths, available in manual or automated formats compatible with major platforms (Kingfisher Flex, Biomek, Hamilton, and others). Biomiga offers comprehensive real-time PCR detection assays targeting infectious disease panels, including respiratory pathogen panels (RPP), sexually transmitted infections (STI), gastrointestinal pathogens, women's health, wound infection markers, and nail fungal detection. The company also provides customized services for gene synthesis, cell line construction, protein expression, lentivirus packaging, and next-generation sequencing. FDA-registered facility with ISO 9001:2015 certification. All extraction protocols are fully validated for automation on industry-standard platforms. The company emphasizes in-house manufacturing control, 24/7 customer support, and R&D-driven product development.

Bio-Rad Laboratories is a global life science and clinical diagnostics company that manufactures and distributes instruments, reagents, consumables, controls, and data management software for research and diagnostics laboratories. The company serves academic research, industrial bioprocessing, and clinical diagnostic markets with a diverse product portfolio spanning PCR and qPCR systems (including proprietary ddPCR digital droplet technology), Western blotting reagents and systems, blood typing and screening products, immunoassay controls, antibodies, cell counting equipment, gel documentation and imaging systems, and process separation solutions for biopharmaceutical purification. Bio-Rad's offerings extend to quality control solutions, specialized testing kits for oncology mutation detection and infectious disease screening, and classroom education products. The company maintains robust e-commerce capabilities including PunchOut procurement integration, quick ordering, order status tracking, and document library management for B2B customers. Product lines include the QX200/QX600 ddPCR platforms, CFX Real-Time PCR systems, TC20 automated cell counters, ChemiDoc imaging systems, and specialized molecular detection kits. Bio-Rad serves clinical laboratories, research institutions, biotech firms, and educational organizations globally with regulatory credentials supporting ISO and FDA compliance across its diagnostics and instrument portfolios.

Twist Bioscience Corporation is a US-based synthetic biology company specializing in DNA-based research tools and services. The company operates a proprietary semiconductor-based synthetic DNA manufacturing platform utilizing high-throughput silicon technology for miniaturized chemistry and cost-efficient DNA synthesis. Core product portfolio includes synthetic genes (clonal genes, gene fragments, gene pools, vectors), oligonucleotide pools (cloned and uncloned), next-generation sequencing (NGS) target enrichment solutions, library preparation kits (including TrueAmp Library Prep Kit and PCR-free WGS kits), variant libraries (combinatorial, site saturation, spread-out low diversity), and synthetic controls for infectious disease and liquid biopsy applications. The company also offers comprehensive antibody discovery and development services including in vitro phage display, in vivo discovery using Diversimab technology and humanized transgenic mice, antibody characterization (SPR, developability assessment, functional assays), and optimization services including AI/ML-driven affinity maturation and in silico humanization. Twist Service Lab provides outsourced sequencing services, and the company offers automation solutions and API-based procurement integration. Target markets include academic research, pharmaceutical drug discovery, cancer research, infectious disease research, agricultural biotechnology, and clinical diagnostics. The platform enables researchers to access customizable gene synthesis at varying scales, perform high-confidence genomic screening, and conduct precision variant detection across NGS workflows.

Mel-Mont Medical Inc is a clinical diagnostics and molecular technology company specializing in HPV-related cancer detection and prevention. The company develops patented, non-invasive self-sampling medical devices coupled with proprietary comprehensive molecular testing platforms for early identification of high-risk human papillomavirus (HR-HPV) infections. The company operates three primary product divisions: (1) Medical Devices—user-friendly, patented devices for HPV-related cancer prevention; (2) In Vitro Diagnostics (PreTect division)—ISO 13485-certified molecular assays for nucleic acid amplification and HPV-mRNA testing with proprietary laboratory services; (3) Sample Preparation Reagents—molecular testing reagents and transport media for sample handling. Mel-Mont Medical maintains a rigorous R&D pipeline following a six-stage development methodology: concept identification, usage characterization, design and development, pilot production and validation, regulatory prelaunch monitoring, and market launch with post-market surveillance. The company conducts preclinical and clinical trials to validate devices before market introduction and emphasizes clinically proven molecular biology technologies. Products are manufactured in compliance with applicable standards. The company serves international markets including the United States, Mexico, Spain, Norway, and Colombia, with distribution and manufacturing partnerships in select regions.

Sinochips Diagnostics is a CLIA & CAP-accredited clinical laboratory specializing in advanced molecular testing for precision medicine and diagnostics. The company offers pharmacogenomics testing (DNA-based medication optimization), infectious disease panels (respiratory pathogens, UTI), and biomarker analysis with rapid turnaround times. Services include multiplex PCR panels, serology testing, and diagnostic rRT-PCR assays, primarily serving healthcare providers, clinics, and hospitals. Sinochips combines state-of-the-art molecular technology with streamlined sample collection, processing, and secure online result portals to enable data-driven clinical decision-making.

Pro-Lab Diagnostics is a Canadian manufacturer and global distributor of clinical diagnostic test kits, laboratory products, and immunodiagnostic reagents. Founded in 1974 and based in Toronto, Ontario, the company serves 45 countries and 15,000 hospitals with over 50 years of expertise. Pro-Lab specializes in clinical microbiology, women's health, molecular diagnostics, and general laboratory supplies. Key product lines include the original TransVelope™ specimen transport bag, AmnioTest™ Nitrazine Swab for OB-GYN testing, Prolex™ Latex Agglutination tests, Microbank® organism storage systems, Prolisa™ ELISA assays, and OptiGene molecular diagnostic solutions. The company provides customized immunodiagnostic solutions, point-of-care training programs, and private labeling services for pharmaceutical manufacturers and research organizations. Certified to ISO 13485:2016 and FDA-registered, Pro-Lab delivers high-quality laboratory diagnostics to hospitals, clinical laboratories, obstetric facilities, and research institutions worldwide.

Spectrum Solutions (Spectrum Health Science) is a vertically integrated medical device and diagnostics manufacturer specializing in salivary diagnostic solutions and non-invasive testing platforms. Operating from Utah with ~840 employees and $213M+ annual revenue, the company offers end-to-end capabilities spanning medical device engineering, molecular diagnostics development, chemical formulation, contract manufacturing, specialized packaging, and global fulfillment. Its flagship SimplyTest® brand delivers direct-to-consumer and clinical-grade salivary tests for oral health, periodontal disease, HPV screening, women's health, and functional medicine markers. The company operates a CAP-accredited, CLIA-certified laboratory and a 50-state licensed pharmacy, enabling national scalability. ISO 13485 certified, Spectrum Solutions serves dental practices, healthcare providers, and DTC channels with companion diagnostics, genomic testing, and custom microarray development. The company is positioned as a single-source provider for IVD (in vitro diagnostics) innovation, particularly in salivary-based molecular testing.